Product logins

Find logins to all Clarivate products below.


The US ENT device market was severely impacted by the COVID-19 pandemic, but has already begun to recover. Growth over the forecast period will be driven mainly by rising nose and sinus procedures, which contribute to revenue for the ENT RF and Powered Device and Sinus Stent markets. Alternate financing models are on the rise for capital equipment sales as facilities attempt to cut overall costs.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ENT devices in the US across a 10-year period.

Related Medtech Insights Reports

Report
Heart Valve Devices | Market Insights | Europe | 2022
The European heart valve device market has been negatively impacted by the global COVID-19 pandemic; however, in the longer term, the market will be driven by an aging population in this country…
Report
Urological Devices | Market Insights | Europe | 2022
The deferral or cancellation of nonessential procedures due to the COVID-19 pandemic negatively impacted the European urological device market in 2020; however, the market will show a strong…
Report
Peripheral Vascular Devices | Market Insights | US | 2022
Following the negative impact of the COVID-19 pandemic, the US market for PV devices will face new challenges brought about by reimbursement changes, while a large undiagnosed patient…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Asia Pacific | 2022
While the COVID-19 pandemic will have a negative but limited impact on the Asia Pacific transcatheter embolization and occlusion device market in the short term, the market will expand at a …
Report
Peripheral Vascular Devices | Market Insights | Latin America (Supplemental) | 2021
Following the negative impact of the COVID-19 pandemic, the US market for PV devices will face new challenges brought about by reimbursement changes, while a large undiagnosed patient…